Table 3 Overall survival of patients with malignant lacrimal gland tumors.
From: Clinical characteristics, radiologic features, and histopathology of biopsied lacrimal gland tumors
Characteristics | n/N | Rate/PY | Median | % of survival by year | p value | Crude HR | p value | |||
|---|---|---|---|---|---|---|---|---|---|---|
1 | 3 | 5 | 10 | |||||||
Overall survival | 14/23 | 0.101 | 7.06 | 90.9 | 71.5 | 60.0 | 43.0 | – | – | – |
Diagnosis | ||||||||||
ACC | 8/9 | 0.126 | 7.06 | 77.8 | 55.6 | 55.6 | 33.3 | 0.578 | 1 | 0.579 |
Lymphoma | 6/14 | 0.081 | 13.32 | 100.0 | 83.3 | 62.5 | 52.1 | 0.73 (0.24, 2.23) | ||
Sex | ||||||||||
Male | 9/16 | 0.105 | 6.04 | 83.7 | 71.5 | 53.6 | 44.7 | 0.976 | 1 | 0.976 |
Female | 5/7 | 0.097 | 7.84 | 100.0 | 71.4 | 71.4 | 35.7 | 1.02 (0.33, 3.13) | ||
Laterality | ||||||||||
Unilateral | 11/19 | 0.093 | 7.84 | 89.5 | 72.3 | 65.7 | 44.4 | 0.405 | 1 | 0.410 |
Bilateral | 3/4 | 0.158 | 3.96 | 100.0 | 66.7 | 33.3 | 33.3 | 1.74 (0.47, 6.51) | ||
Duration of symptoms (months) | ||||||||||
≤ 1 | 2/4 | 0.053 | 7.84 | 100.0 | 100.0 | 75.0 | 50.0 | 0.592 | 1 | |
> 1–3 | 2/6 | 0.146 | – | 80.0 | 60.0 | 60.0 | 60.0 | 2.65 (0.34, 20.53) | 0.351 | |
> 3 | 10/13 | 0.117 | 7.06 | 92.2 | 67.1 | 58.7 | 42.0 | 1.98 (0.43, 9.20) | 0.384 | |
